Skip to main content
XRAY
NASDAQ Life Sciences

首款牙科MRI系统在成功的临床试验后获得FDA批准

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
8
Price
$12.62
Mkt Cap
$2.545B
52W Low
$9.85
52W High
$17.18
Market data snapshot near publication time

summarizeSummary

Dentsply Sirona与Siemens Healthineers合作宣布，他们的首款专用牙科MRI（ddMRI）系统MAGNETOM Free.Max Dental Edition，在成功的临床试验后获得了美国FDA的批准。这一创新的系统为各种牙科专业（包括根管治疗、牙周病治疗和颞下颌关节）提供了非电离的软组织成像诊断。这种积极的产品发展为Dentsply Sirona提供了急需的提振，该公司最近报告了2025财年的重大净亏损、重大重组以及取消了其股息。FDA的批准允许该公司商业化一款独特的产品，这款产品可能会提高诊断能力并扩大公司的成像产品组合。投资者将密切关注商业推出的细节、采用率以及这项新技术的潜在收入贡献。

在该公告发布时，XRAY的交易价格为$12.62，交易所为NASDAQ，所属行业为Life Sciences，市值约为$25.4亿。 52周交易区间为$9.85至$17.18。 这则新闻被评估为积极市场情绪，重要性评分为8/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed XRAY - Latest Insights

XRAY
Apr 23, 2026, 4:32 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Dentsply Sirona Seeks Shareholder Approval for 15 Million Share Increase in Incentive Plan
Sentiment: Negative
View Wiseek Article
XRAY
Mar 09, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
First-Ever Dental MRI System Cleared by FDA After Successful Clinical Trial
Sentiment: Positive
View Wiseek Article
XRAY
Mar 03, 2026, 7:12 PM EST
Filing Type: 4
Importance Score:
7
Director Buys $707K in Open Market Shares Following Recent Negative Earnings and Restructuring News
Sentiment: Positive
View Wiseek Article
XRAY
Feb 26, 2026, 5:58 PM EST
Source: Dow Jones Newswires
Importance Score:
8
Dentsply Sirona Posts Narrower 4Q Loss, Restructures
Sentiment: Positive
View Wiseek Article
XRAY
Feb 26, 2026, 5:06 PM EST
Source: dpa-AFX
Importance Score:
8
Dentsply Sirona Q4 Loss Narrows
Sentiment: Positive
View Wiseek Article
XRAY
Feb 26, 2026, 4:54 PM EST
Filing Type: 10-K
Importance Score:
8
Dentsply Sirona Reports Significant 2025 Net Loss, Suspends Dividends, and Announces New Restructuring Plan
Sentiment: Negative
View Wiseek Article
XRAY
Feb 26, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
8
Dentsply Sirona Reports Significant FY25 Loss, Announces Major Restructuring & Dividend Elimination for Debt/Buybacks
Sentiment: Neutral
View Wiseek Article
XRAY
Feb 24, 2026, 4:35 PM EST
Filing Type: 8-K
Importance Score:
7
Dentsply Sirona Appoints Two Highly Experienced Directors to Bolster "Return-to-Growth" Strategy
Sentiment: Positive
View Wiseek Article
XRAY
Jan 14, 2026, 7:55 AM EST
Filing Type: 8-K
Importance Score:
7
Dentsply Sirona Renews Key U.S. Dental Technology Distribution Partnership with Patterson Dental
Sentiment: Positive
View Wiseek Article
XRAY
Jan 13, 2026, 7:55 AM EST
Filing Type: 8-K
Importance Score:
7
Dentsply Sirona Appoints Donald Zurbay to Board, Forms Growth & Value Creation Committee
Sentiment: Positive
View Wiseek Article